The main medications used for OCD are a class of antidepressants called SSRIs, which work by increasing serotonin activity in the brain. Several are FDA-approved specifically for OCD, and they remain the standard first-line treatment. What makes OCD unique is that it typically requires higher doses and longer treatment windows than the same medications need for depression or anxiety.
SSRIs: The First-Line Medications
SSRIs (selective serotonin reuptake inhibitors) are the most widely prescribed medications for OCD. The ones FDA-approved for this condition include fluoxetine (Prozac), fluvoxamine (Luvox), paroxetine (Paxil), and sertraline (Zoloft). Other SSRIs like escitalopram (Lexapro) and citalopram (Celexa) are sometimes used off-label as well, since the entire class works through the same mechanism.
A critical detail many people don’t realize: OCD doses are significantly higher than what’s prescribed for depression. Studies show that dosages two to three times higher than typical depression doses produce the best results for OCD. For example, an adequate trial might require at least 40 to 60 mg per day of fluoxetine, or 200 to 300 mg per day of sertraline. This is important context if you’ve taken an SSRI for another condition before and found that a lower dose worked fine. OCD is a different situation.
Why OCD Medications Take Longer to Work
One of the most frustrating aspects of OCD medication is the timeline. Benefits typically don’t become noticeable until about six weeks in, and for some people it takes a full eight weeks before any improvement begins. A complete trial, meaning enough time to know whether a medication is actually working, requires 10 to 12 weeks at the highest dose you can comfortably tolerate. That’s nearly three months on a single medication before you and your prescriber can make a confident call about whether it’s the right one.
This means that switching medications too quickly, or giving up after a few weeks of no change, can lead to abandoning a drug that might have worked with more time. Patience during this period is genuinely part of the treatment.
Clomipramine: An Older but Potent Option
Clomipramine (Anafranil) is an older type of antidepressant called a tricyclic that was actually the first medication approved for OCD. It affects serotonin powerfully and is sometimes more effective than SSRIs for certain patients. However, it comes with a heavier side effect burden, which is why it’s generally tried after SSRIs haven’t worked well enough.
Common side effects include drowsiness, dry mouth, constipation, weight changes, decreased sexual function, and difficulty concentrating. More serious but rarer effects can include seizures, rapid heartbeat, and difficulty urinating. Because of these risks, clomipramine is not typically recommended for older adults. It is, however, FDA-approved for children ages 10 to 17 with OCD.
Medications for Children and Teens
Several medications carry specific FDA approval for treating OCD in younger patients. Sertraline is approved starting at age 6, fluoxetine at age 7, and fluvoxamine at age 8. Clomipramine is approved for ages 10 and up. These are the only medications with formal pediatric OCD approval, though prescribers sometimes use other SSRIs off-label depending on the child’s response and tolerability.
When the First Medication Doesn’t Work
Roughly 40 to 60 percent of people with OCD don’t get adequate relief from their first SSRI alone. When that happens, prescribers have several options: switching to a different SSRI, trying clomipramine, or adding a second medication on top of the SSRI. This “add-on” approach is called augmentation, and it’s one of the most studied strategies for treatment-resistant OCD.
The most common augmentation medications are low-dose antipsychotics. Despite the name, these aren’t prescribed because OCD involves psychosis. They work on different brain pathways, particularly dopamine, that may play a role in OCD symptoms that don’t respond to serotonin-based treatment alone. Aripiprazole is one of the most studied options, with clinical trials showing response rates ranging from about 30 to 42 percent in patients who hadn’t improved enough on an SSRI alone. Some smaller studies have reported higher response rates, though results vary.
Newer medications in this category are also showing promise. In a study of 34 adults with treatment-resistant OCD, 50 percent of those who added brexpiprazole to their existing SSRI met response criteria after 12 weeks. Cariprazine, another newer option, showed a 61.5 percent response rate in a small study of 13 patients. These are preliminary numbers from small studies, but they give prescribers additional tools when standard approaches fall short.
Glutamate-Targeting Supplements and Medications
Beyond serotonin and dopamine, researchers have been investigating the role of glutamate, the brain’s primary excitatory chemical messenger, in OCD. N-acetylcysteine (NAC), an over-the-counter supplement, modulates glutamate levels and has been studied as an add-on to SSRIs. A meta-analysis of clinical trials found that NAC added to SSRIs may benefit patients with moderate to severe OCD, with improvements appearing in the five to eight week range. The effect wasn’t significant at shorter durations or beyond 12 weeks, and the supplement showed no meaningful difference in side effects compared to placebo. Doses in the studies ranged from 600 to 3,000 mg per day.
Memantine, a prescription medication originally developed for Alzheimer’s disease, has also been investigated for OCD because of its effects on glutamate. Evidence here is still limited, and it remains an off-label option that some specialists consider for difficult cases.
Medication Combined With Therapy
Medication for OCD works best when paired with a specific type of cognitive behavioral therapy called exposure and response prevention (ERP). ERP involves gradually facing the situations that trigger obsessive thoughts while practicing not performing the compulsive behaviors. The combination of medication and ERP consistently outperforms either approach alone. For many people, medication reduces the intensity of OCD symptoms enough that engaging in therapy becomes more manageable, and therapy builds skills that medication alone can’t provide.
Some people eventually taper off medication after sustained improvement with therapy, while others stay on it long-term. The decision depends on symptom severity, how well you’ve responded, and your own preferences. Stopping OCD medication abruptly can cause withdrawal symptoms and symptom rebound, so any changes should be gradual and planned.